{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T18:48:09Z","timestamp":1786819689083,"version":"build-2736575974"},"reference-count":29,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.3892\/ol.2017.6074","type":"journal-article","created":{"date-parts":[[2017,4,21]],"date-time":"2017-04-21T08:14:51Z","timestamp":1492762491000},"page":"4741-4747","source":"Crossref","is-referenced-by-count":9,"title":["Therapeutic results of a novel enzyme-targeting radiosensitization treatment, Kochi oxydol-radiation therapy for unresectable carcinomas II, in patients with stage I primary breast cancer"],"prefix":"10.3892","volume":"13","author":[{"given":"Nobutaka","family":"Aoyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Yasuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenta","family":"Ohgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitomi","family":"Iwasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kana","family":"Miyatake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rika","family":"Yoshimatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoaki","family":"Yamanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiko","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiji","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kana","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoriko","family":"Murata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhiko","family":"Miyamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuji","family":"Yamagami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2017,4,21]]},"reference":[{"key":"key20180108113816_b1-ol-0-0-6074","doi-asserted-by":"crossref","first-page":"21","DOI":"10.14694\/EdBook_AM.2014.34.21","article-title":"Fifty years of progress in radiation therapy for breast cancer","author":"Harris","year":"2014","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"key20180108113816_b2-ol-0-0-6074","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/BF02303848","article-title":"Selection of local therapy after neoadjuvant chemotherapy in patients with Stage IIIA, B breast cancer","volume":"5","author":"Danforth","year":"1998","journal-title":"Ann Surg Oncol"},{"key":"key20180108113816_b3-ol-0-0-6074","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S1470-2045(15)70064-1","article-title":"Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): A randomized, open-label, multicenter, phase 3 trial","volume":"16","author":"Hu","year":"2015","journal-title":"Lancet Oncol"},{"key":"key20180108113816_b4-ol-0-0-6074","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s12282-012-0336-3","article-title":"The role of chemoradiotherapy in patients with unresectable T4 breast tumors","volume":"20","author":"Karasawa","year":"2013","journal-title":"Breast Cancer"},{"key":"key20180108113816_b5-ol-0-0-6074","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s11596-013-1108-9","article-title":"Unfavorable pathological complete response rate of neoadjuvant chemotherapy epirubicin plus taxanes for locally advanced triple-negative breast cancer","volume":"33","author":"Yin","year":"2013","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"key20180108113816_b6-ol-0-0-6074","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.clbc.2014.10.007","article-title":"Efficacy of concurrent chemoradiotherapy for patients with locally recurrent or advanced inoperable breast cancer","volume":"15","author":"Shaughnessy","year":"2015","journal-title":"Clin Breast Cancer"},{"key":"key20180108113816_b7-ol-0-0-6074","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1016\/j.ejca.2006.03.026","article-title":"Pathological response to preoperative concurrent chemo-radiotherapy for breast cancer: Results of a phase II study","volume":"42","author":"Bollet","year":"2006","journal-title":"Eur J Cancer"},{"key":"key20180108113816_b8-ol-0-0-6074","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00066-012-0162-8","article-title":"Long-term outcome after neoadjuvant radiochemotherapy in locally advanced noninflammatory breast cancer and predictive factors for a pathologic complete remission: Results of a multivariate analysis","volume":"188","author":"Matuschek","year":"2012","journal-title":"Strahlenther Onkol"},{"key":"key20180108113816_b9-ol-0-0-6074","first-page":"3929","article-title":"Value of high-dose radiation therapy for isolated osseous metastasis in breast cancer in terms of oligo-recurrence","volume":"28","author":"Niibe","year":"2008","journal-title":"Anticancer Res"},{"key":"key20180108113816_b10-ol-0-0-6074","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/jjco\/hyp167","article-title":"Oligometastases and oligo-recurrence: The new era of cancer therapy","volume":"40","author":"Niibe","year":"2010","journal-title":"Jpn J Clin Oncol"},{"key":"key20180108113816_b11-ol-0-0-6074","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s10549-008-0157-4","article-title":"Oligometastatic breast cancer treated with curative-intent stereotactic body radiation therapy","volume":"115","author":"Milano","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"key20180108113816_b12-ol-0-0-6074","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/sj.bjc.6603987","article-title":"Concomitant intensive chemoradiotherapy induction in non-metastatic inflammatory breast cancer: Long-term follow-up","volume":"97","author":"Genet","year":"2007","journal-title":"Br J Cancer"},{"key":"key20180108113816_b13-ol-0-0-6074","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1159\/000355196","article-title":"Final results of a safety and efficacy trial of preoperative sequential chemoradiation therapy for the nonsurgical treatment of early breast cancer: Japan Clinical Oncology Group Study JCOG0306","volume":"85","author":"Mukai","year":"2013","journal-title":"Oncology"},{"key":"key20180108113816_b14-ol-0-0-6074","doi-asserted-by":"crossref","first-page":"e0125006","DOI":"10.1371\/journal.pone.0125006","article-title":"Interrogating a multifactorial model of breast conserving therapy with clinical data","volume":"10","author":"Salmon","year":"2015","journal-title":"PLoS One"},{"key":"key20180108113816_b15-ol-0-0-6074","doi-asserted-by":"crossref","first-page":"e339","DOI":"10.1097\/01.GOX.0000464833.67493.fd","article-title":"Aesthetic evaluation in oncoplastic and conservative breast surgery: A comparative analysis","volume":"3","author":"Massa","year":"2015","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"key20180108113816_b16-ol-0-0-6074","first-page":"553","article-title":"Safety and effectiveness of a new enzyme-targeting radiosensitization treatment (KORTUC II) for intratumoral injection for low-LET radioresistant tumors","volume":"39","author":"Ogawa","year":"2011","journal-title":"Int J Oncol"},{"key":"key20180108113816_b17-ol-0-0-6074","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.3390\/cancers3033496","article-title":"Evaluation of changes in tumor shadows and microcalcifications on mammography following KORTUC II, a new radiosensitization treatment without any surgical procedure for elderly patients with stage I and II breast cancer","volume":"3","author":"Tsuzuki","year":"2011","journal-title":"Cancers (Basel)"},{"key":"key20180108113816_b18-ol-0-0-6074","doi-asserted-by":"crossref","first-page":"215","DOI":"10.14312\/2052-4994.2013-32","article-title":"Therapeutic response to a new enzyme-targeting radiosensitization treatment (KORTUC-SC) for patients with chemotherapy-resistant supraclavicular lymph node metastasis","volume":"1","author":"Aoyama","year":"2013","journal-title":"J Cancer Res Ther"},{"key":"key20180108113816_b19-ol-0-0-6074","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3892\/ol.2016.4589","article-title":"Therapeutic response to a novel enzyme-targeting radiosensitization treatment (Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas) in patients with recurrent breast cancer","volume":"12","author":"Aoyama","year":"2016","journal-title":"Oncol Lett"},{"key":"key20180108113816_b20-ol-0-0-6074","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3892\/ol.2016.5456","article-title":"Therapeutic response to a novel enzyme-targeting radiosensitization treatment (KORTUC II) for residual lesions in patients with stage IV primary breast cancer, following induction chemotherapy with epirubicin and cyclophosphamide or taxane","volume":"13","author":"Aoyama","year":"2017","journal-title":"Oncol Lett"},{"key":"key20180108113816_b21-ol-0-0-6074","first-page":"100","article-title":"Development and clinical application of a new radiosensitizer containing hydrogen peroxide and hyaluronic acid sodium for topical tumor injection-a new enzyme-targeting radiosensitization treatment, KORTUC II (Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas, Type II)","volume":"183","author":"Ogawa","year":"2007","journal-title":"Strahlenther Onkol"},{"key":"key20180108113816_b22-ol-0-0-6074","first-page":"1389","article-title":"New radiosensitization treatment (KORTUC I) using hydrogen peroxide solution-soaked gauze bolus for unresectable and superficially exposed neoplasms","volume":"19","author":"Ogawa","year":"2008","journal-title":"Oncol Rep"},{"key":"key20180108113816_b23-ol-0-0-6074","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3892\/ijo_00000186","article-title":"Phase I study of a new radiosensitizer containing hydrogen peroxide and sodium hyaluronate for topical tumor injection: A new enzyme-targeting radiosensitization treatment, kochi oxydol-radiation therapy for unresectable carcinomas, Type II (KORTUC II)","volume":"34","author":"Ogawa","year":"2009","journal-title":"Int J Oncol"},{"key":"key20180108113816_b24-ol-0-0-6074","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.3892\/or_00000968","article-title":"Non-surgical care for locally advanced breast cancer: Radiologically assessed therapeutic outcome of a new-enzyme-targeting radiosensitization treatment, Kochi oxydol-radiation therapy for unresectable carcinomas, type II (KORTUC II) with systemic chemotherapy","volume":"24","author":"Miyatake","year":"2010","journal-title":"Oncol Rep"},{"key":"key20180108113816_b25-ol-0-0-6074","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.3892\/ol.2010.184","article-title":"Development of a novel enzyme-targeting radiosensitizer (KORTUC) containing hydrogen peroxide for intratumoral injection for patients with low linear energy transfer-radioresistant neoplasms","volume":"1","author":"Tokuhiro","year":"2010","journal-title":"Oncol Lett"},{"key":"key20180108113816_b26-ol-0-0-6074","doi-asserted-by":"crossref","first-page":"769","DOI":"10.3892\/etm.2010.123","article-title":"Non-surgical therapy and radiologic assessment of stage I breast cancer treatment with novel enzyme-targeting radiosensitization: Kochi Oxydol-radiation therapy for unresectable carcinomas, type II (KORTUC II)","volume":"1","author":"Hitomi","year":"2010","journal-title":"Exp Ther Med"},{"key":"key20180108113816_b27-ol-0-0-6074","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000430488","article-title":"St. Gallen\/Vienna 2015: A Brief Summary of the Consensus Discussion","volume":"10","author":"Gnant","year":"2015","journal-title":"Breast Care (Basel)"},{"key":"key20180108113816_b28-ol-0-0-6074","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1200\/JCO.2006.06.1366","article-title":"Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: Ten-year results of European Organisation for research and treatment of cancer randomized phase III trial 10853-a study by the EORTC breast cancer cooperative group and EORTC radiotherapy group","volume":"24","author":"EORTC Breast Cancer Cooperative Group","year":"2006","journal-title":"J Clin Oncol"},{"key":"key20180108113816_b29-ol-0-0-6074","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/S0140-6736(11)61629-2","article-title":"Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials","volume":"378","author":"Early Breast Cancer Trialists' Collaborative Group (EBCTCG)","year":"2011","journal-title":"Lancet"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2017.6074\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T11:22:48Z","timestamp":1515410568000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2017.6074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,21]]},"references-count":29,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,4,21]]},"published-print":{"date-parts":[[2017,6]]}},"alternative-id":["10.3892\/ol.2017.6074"],"URL":"https:\/\/doi.org\/10.3892\/ol.2017.6074","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,21]]}}}